logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Nektar Therapeutics Q1 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$138.65 million in Q1 vs. -$119.63 million in the same period last year.
-EPS: -$0.78 in Q1 vs. -$0.69 in the same period last year.
-Analysts projected -$0.71 per share
-Revenue: $50.57 million in Q1 vs. $28.22 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT